FridayNov 04, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Zero Adverse Effects from Successful HYPER-H21-4 Study of DehydraTECH(TM)-CBD for High Blood Pressure

The CDC reported more than 670,000 annual deaths in the United States with high blood pressure as a primary or contributing cause Lexaria's patented DehydraTECH(TM) technology has been shown, through HYPER-H21-4 study, to decrease high blood pressure in subjects through DehydraTECH-CBD-enabled dosing The global antihypertension drug market was valued at over $22.5 billion in revenue in 2018 and is expected to grow at a CAGR of 3.1%, resulting in a market of over $28.7 billion by 2026 In the United States, uncontrolled high blood pressure is common among adults – with only one in four having the condition under control.…

Continue Reading

FridayNov 04, 2022 10:04 am

QualityStocksNewsBreaks – CubCrafters, Missionary Pilot Partner to Fly Life-Saving Missions in Mexico

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23-certified backcountry aircraft, has built aircraft that has been flown around the world for many reasons. Brent Dodd and his CubCrafters Carbon Cub EX are flying for what may be the most important reason of all — to save lives. Serving in Mexico for the United Indian Mission, Dodd is the organization’s director of flight operations; he also serves as an airframe and power-plant mechanic and is the pilot of the Carbon Cub, which has been slightly modified for its life-saving work. According to Dodd, who was featured in a…

Continue Reading

FridayNov 04, 2022 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Extends Columbia University Agreement to Continue Research for Therapeutics to Treat Alzheimer’s Disease

Silo recently extended Columbia University agreement to continue research for novel therapeutics to treat Alzheimer’s disease and stress-induced anxiety disorder Preclinical studies demonstrate Silo’s jointly-developed Z-pod(TM) delivery technology holds and distributes therapeutics in a time-released manner to potentially provide targeted delivery Additional treatment research includes funding for the UCSF Translational Psychedelic Program to study effects of psilocybin on various inflammatory conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company, fuses traditional therapeutics with psychedelic medicine to treat numerous underserved conditions, including fibromyalgia, post-traumatic stress disorder, and Alzheimer’s disease. Through a joint partnership agreement with Columbia University, researchers are currently…

Continue Reading

ThursdayNov 03, 2022 3:02 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Benefiting as Utilities Look to Reduce Dependence on Fossil Fuels

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is among companies that are rising to the challenge to provide RNG solutions for utilities increasingly looking to slash pollution and reduce the world’s dependence on fossil fuels. “Climate change awareness has consumers, regulators and companies alike clamoring about implementing sustainable alternatives to natural gas, driving demand for RNG. This benefits EverGen, which has contracts with utilities and municipalities to produce and sell its RNG,” reads a recent article. “EverGen was initially focused within its home province of British Columbia, where…

Continue Reading

ThursdayNov 03, 2022 2:53 pm

QualityStocksNewsBreaks – REZYFi Inc. Leveraging Experience, Independent Broker Network and Proprietary Technology as Pillars for Success

REZYFi is positioned as one of the first cannabis mortgage bankers in the U.S., where most traditional lenders are reticent to serve the state-licensed cannabis industry. “The company operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation,” a recent article reads. The piece further discusses the company’s use of multiple corporate strengths for its success. “Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team…

Continue Reading

ThursdayNov 03, 2022 2:41 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Confident in Preclinical Work on Its Novel Ketamine Formulation

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company, is focused on fusing traditional therapeutics with psychedelic research to provide novel treatments for numerous indications, including post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s disease, and other rare neurological disorders. “Silo Pharma is currently developing ketamine treatments for fibromyalgia – a chronic disease that causes pain throughout the body. With no cure available, fibromyalgia can be a debilitating condition that extends beyond the pain to cause extreme fatigue, anxiety and memory issues. Silo’s novel ketamine formulation, designated as SP-26, is currently undergoing safety evaluation to treat fibromyalgia,” reads a recent article. “We are…

Continue Reading

ThursdayNov 03, 2022 1:05 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Offer Options for Farmers Looking to Meet Changing Food Demands

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, offer numerous benefits for farmers looking to be dynamic and fluid. GrowPods are unique controlled environment farms that don’t use expensive, dangerous pesticides and herbicides and provide a way for farmers to identify crops that are in short supply and then grow those crops, quickly and efficiently. A recent CNBC report noted that there is currently a “massive strain on global food supply,” especially as the world recovers from the global pandemic. That need, combined with the increasing costs of fertilizer and pesticides, make…

Continue Reading

ThursdayNov 03, 2022 12:57 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Announces Expansion of Executive Team

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a medical technology company focused on developing unique, life-saving medical products, is expanding its executive team. The expansion is part of ODYY’s support of and commitment to Odyssey NeuroPharma, the company’s newest entity. Additions to the executive team include Erik Emerson, named chief commercial officer, and Greg Gironda, named chief operating officer. These two together have more than five decades of experience in commercializing innovative pharmaceutical compounds with leading pharmaceutical companies; the pair will work to advance Odyssey’s concussion treatment and Niemann-Pick treatment. According to the announcement, more than 5 million…

Continue Reading

ThursdayNov 03, 2022 12:44 pm

QualityStocksNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Announces Plans to Report Q3 2022 Financial Results

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, is planning to release its third quarter 2022 financial report this month. The company announced that it will release the report on Nov. 14, 2022. On the same day, RYVYL executives will host a conference call and webcast to discuss the released report; the event will start at 4:30 p.m. ET. During the call, management will provide a summary of financial results as well as a corporate update; in addition, the event will include an audio Q&A session…

Continue Reading

ThursdayNov 03, 2022 12:21 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 13th Craig-Hallum Alpha Select Conference

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 13th Craig-Hallum Alpha Select Conference. The event is slated to be held in New York City on Nov. 17, 2022. Cepton management will be available for group investor or one-on-one meetings throughout the conference. Interested parties should contact InvestorRelations@Cepton.com or their Craig-Hallum representative for related inquiries. To view the full press release, visit https://ibn.fm/8QIlk About Cepton Inc. Cepton is a Silicon Valley innovator of lidar-based solutions…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered